Anthrax vaccine: short-term safety experience in humans

By Pittman P.R.   Gibbs P.H.   Cannon T.L.   Friedlander A.M.  

Vaccine, Vol. 20, Iss. 5, 2001-12 ,pp. : 972-978

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a new inactivated hepatitis A vaccine: a clinical trial with comparison of administration route

By Fisch A.   Cadilhac P.   Vidor E.   Prazuck T.   Dublanchet A.   Lafaix C.  

Vaccine, Vol. 14, Iss. 12, 1996-08 ,pp. : 1132-1136

Elsevier

Access to resources Recommend Favorite

Study of the safety, immunogenicity and seroconversion of a hepatitis-B vaccine in malnourished children of India

By Lakshmi G.   Reddy R.P.S.   Kumar K.K.R.   Bhavani N.V.   Dayanand M.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2009-2014

Elsevier

Access to resources Recommend Favorite

Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais

By Cryz S.J.   Poovorawan Y.   Theamboonlers A.   Chumdermpadetsuk S.   Gluck R.  

Vaccine, Vol. 13, Iss. 10, 1995-07 ,pp. : 891-893

Elsevier

Access to resources Recommend Favorite

Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity

By Ehrlich H.J.   Pavlova B.G.   Fritsch S.   Poellabauer E.-M.   Loew-Baselli A.   Obermann-Slupetzky O.   Maritsch F.   Cil I.   Dorner F.   Barrett P.N.  

Vaccine, Vol. 22, Iss. 2, 2003-12 ,pp. : 217-223

Elsevier

Access to resources Recommend Favorite